|
Originally published In Press as doi:10.1074/jbc.M004136200 on September 14, 2000
J. Biol. Chem., Vol. 275, Issue 49, 38268-38274, December 8, 2000
Fetal Alcohol Exposure Alters Neurosteroid Modulation of
Hippocampal N-Methyl-D-aspartate Receptors*
Edmar T.
Costa,
Dorian S.
Olivera,
Douglas A.
Meyer,
Vania M. M.
Ferreira,
Eli E.
Soto,
Shanti
Frausto,
Daniel D.
Savage,
Michael
D.
Browning , and
C. Fernando
Valenzuela§
From the Department of Neurosciences, University of New Mexico
Health Sciences Center, Albuquerque, New Mexico 87131-5223 and
Department of Pharmacology, University of Colorado Health
Sciences Center, Denver, Colorado 80262
Received for publication, May 15, 2000, and in revised form, August 23, 2000
 |
ABSTRACT |
The actions of ethanol on brain ligand-gated ion
channels have important roles in the pathophysiology of alcohol-related
neurodevelopmental disorders and fetal alcohol syndrome. Studies have
shown that N-methyl-D-aspartate (NMDA)
receptors are among the ligand-gated ion channels affected by prenatal
ethanol exposure. We exposed pregnant dams to an ethanol-containing
liquid diet that results in blood ethanol levels near the legal
intoxication limit in most states (0.08%). Primary cultures of
hippocampal neurons were prepared from the neonatal offspring of these
dams, and NMDA receptor function was assessed by patch clamp
electrophysiological techniques after 6-7 days in culture in
ethanol-free media. Unexpectedly, we did not detect any changes in
hippocampal NMDA receptor function at either the whole-cell or
single-channel levels. However, we determined that fetal alcohol
exposure alters the actions of the neurosteroids pregnenolone sulfate
and pregnenolone hemisuccinate, which potentiate NMDA receptor
function. Western immunoblot analyses demonstrated that this alteration
is not due to a change in the expression levels of NMDA receptor
subunits. Importantly, in utero ethanol exposure did not
affect the actions of neurosteroids that inhibit NMDA receptor
function. Moreover, the actions of pregnenolone sulfate on type A
-aminobutyric acid and non-NMDA receptor function were unaltered by
ethanol exposure in utero, which suggests that the
alteration is specific to NMDA receptors. These findings are significant because they provide, at least in part, a plausible mechanistic explanation for the alterations in the behavioral responses
to neurosteroids found in neonatal rats prenatally exposed to ethanol
and to other forms of maternal stress (Zimmerberg, B., and McDonald,
B. C. (1996) Pharmacol. Biochem. Behav. 55, 541-547).
 |
INTRODUCTION |
Ingestion of ethanol during pregnancy can have profound effects on
normal fetal development. These effects range from isolated alcohol-related birth defects to a combination of abnormalities that
characterize the fetal alcohol syndrome (1). This syndrome is
characterized by alterations in growth, facial and skull development, and central nervous system function. Fetal ethanol exposure produces long-lasting and debilitating neurobehavioral and neurophysiological dysfunctions such as deficits in learning, memory, information processing, and problem solving skills (2-5). Therefore, there is
considerable interest in understanding the consequences of the
teratogenic actions of ethanol in the central nervous system.
Research from a number of laboratories suggests that the actions of
ethanol on ligand-gated ion channels have important roles in the
pathophysiology of alcohol-related neurodevelopmental disorders (for
review, see Ref. 6). Experimental evidence indicates that glutamate
receptors of the N-methyl-D-aspartate
(NMDA)1 subtype are among the
ligand-gated ion channels affected by fetal exposure to ethanol.
Studies have shown that fetal and/or neonatal ethanol exposure alters
ligand binding to NMDA receptors and expression of NMDA receptor
subunits (7-11). Reductions in NMDA receptor function have also been
detected in neuronal preparations from both the neonatal and the adult
offspring of rats exposed to ethanol during pregnancy (6, 12-15).
Since the normal functioning of NMDA receptors is critical for growth,
proliferation, differentiation, migration, plasticity, and programmed
death of neurons (16-23), the effects of ethanol on fetal NMDA
receptors could seriously affect normal neurodevelopment and have
long-lasting consequences later in life.
The participation of the NMDA-Rs in complex neurodevelopmental and
neurobehavioral processes requires precise regulation of the function
of these channels. Among the molecules that regulate NMDA receptors are
the neurosteroids, which produce rapid effects on the function of these
receptors by nongenomic mechanisms. Compounds such as
dehydroepiandrosterone and pregnenolone sulfate (PS) enhance NMDA-R
function (24-28). This neurosteroid-mediated enhancement of NMDA-R
function was shown to have a role in axonal elongation in developing
neurons (25). Dehydroepiandrosterone and PS were also shown to enhance
cognitive performance and to have anxiogenic effects in rodents
(29-32). Importantly, Zimmerberg and collaborators found that prenatal
ethanol exposure reduced the anxiogenic effect of PS in neonates
subjected to maternal separation-induced stress (33). The authors of
this study postulated that alterations in the sensitivity of
ligand-gated ion channels to neurosteroids could mediate these effects
of prenatal ethanol exposure. It is noteworthy, however, that the
mechanism by which prenatal alcohol exposure produces these alterations
in the behavioral responses to neurosteroids has yet to be determined.
We have investigated the effects of fetal ethanol exposure on NMDA-R
function and modulation by neurosteroids. Rats consumed a liquid diet
that produces blood ethanol levels of ~0.08%, which are near the
legal intoxication limit in many states. We then prepared primary
cultures of hippocampal neurons from the offspring of these rats and
used patch clamp electrophysiological techniques to assess NMDA-R
function after 6-7 days in culture. We found that exposure to ethanol
during pregnancy affects the sensitivity of NMDA-Rs to neurosteroids.
 |
EXPERIMENTAL PROCEDURES |
Ethanol Liquid Diet Paradigm
Details of the breeding colony procedures have been described
previously (34). Five-month-old Harlan Sprague-Dawley rat dams (Harlan
Industries, Indianapolis, IN) were individually housed in plastic cages
in a temperature-controlled room (22 °C) on a 16-h dark:8-h light
schedule (lights off from 5:30 p.m. to 9:30 a.m.). Beginning on day 1 of gestation, rat dams were assigned to one of the three diet groups.
Two of the three diets consisted of a liquid diet based on the
Lieber-DeCarli (35) formulation, which provides 1 kcal/ml (BioServ,
Frenchtown, NJ). These groups received 110 ml of liquid diet at 5:30
p.m. each day. The feeding tubes were removed 16 h later (at 9:30
a.m. on the next morning). The fetal ethanol-exposed group received a
liquid diet containing no ethanol for the first 2 days of gestation for
adjustment to the liquid diet. The animals in this group were then
given 110 ml of a liquid diet containing 2% (v/v) ethanol for the
gestational days 3-4, 3% (v/v) for the next 2 days, and thereafter
5% (v/v) ethanol (26% ethanol-derived calories) until they gave
birth. This diet produces blood alcohol levels of ~0.08% (34). The other liquid diet group, serving as pair-fed control, was given a 0%
ethanol liquid diet (isocalorically equivalent to the 5% ethanol diet)
each day throughout the gestation. A third diet group had continuous
access to Purina breeder block chow and water ad libitum and
served as control for the paired feeding technique. At birth, all
litters were weighed and counted.
Primary Cultures of Hippocampal Neurons
Cultures were prepared from 3-4-day-old rats. Meninge-free
hippocampi were microdissected in cold sterile phosphate-buffered saline plus 15 mM HEPES, 27 mM glucose, 17.5 mM sucrose, pH 7.4, with a final osmolarity of 320-335
mosmol. Isolated hippocampi were incubated for 10 min at 37 °C in
0.05% trypsin-EDTA (Life Technologies, Inc.), transferred to
neurobasal A media (Life Technologies, Inc.) containing 10% fetal
bovine serum, and then gently triturated with a Pasteur pipette.
Trituration was repeated with a Pasteur pipette flamed to half its
original opening size. Cells were then plated at a density of
15-20 × 103/ml of media in culture dishes containing
coverslips coated with polylysine and collagen and maintained at
37 °C with 5% CO2 in a humidified atmosphere. Cells
were initially plated in neurobasal A media (Life Technologies, Inc.)
containing 10% fetal bovine serum, 100 units/ml penicillin, 0.1 mg/ml
streptomycin, and 25 µM glutamate. After 24 h, fetal
bovine serum was substituted with the B27 supplement (Life
Technologies, Inc.) and after 3 days in culture, glutamate was removed
from the culture media. Cells were used for experiments after 6-7 days
in culture. Neurons used for recordings were large and had pyramidal
shape and well defined dendritic processes.
Patch Clamp Electrophysiological Recordings
Whole-cell Configuration--
Immediately before recording,
coverslips were transferred to a perfusion chamber (Warner Instruments,
Hampden, CT), and neurons were visualized under a Zeiss inverted
microscope equipped with Varel contrast optics or under an Olympus
microscope equipped with Hoffman modulation optics. Membrane potentials
were clamped at 60 mV with an Axopatch 200B amplifier (Axon
Instruments, Foster City, CA). The resting membrane potential for the
recorded neurons was approximately 60 mV. Recording pipettes
(borosilicate capillaries with filament, outer diameter 1.5 mm, Sutter
Instruments, Novato, CA) were prepared with a two-step puller
(Narishige Instrument Co, Tokyo, Japan) and had resistances between
5-9 megaohms. Series resistance was not compensated. The external
solution (all chemicals from Sigma) contained 130 mM NaCl,
5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM HEPES, pH 7.3, 11 mM glucose, and 300 nM tetrodotoxin. For NMDA
recordings, this solution was nominally Mg2+-free. The
internal solution contained (all chemicals from Fluka, Milwaukee, WI)
130 mM KCl, 10 mM HEPES, 0.1 mM
CaCl2, 1 mM EGTA, 2 mM ATP, and 0.2 mM GTP. For recordings of kainate and GABAA receptor-mediated currents, glass microelectrodes were front-filled with internal solution containing (all chemicals were from Fluka) 155 mM KCl, 10 mM HEPES, pH 7.3, 5 mM
EGTA, and 1 mM MgCl2 adjusted to 285 mosmol.
Pipettes were then back-filled with the same internal solution
containing 50 units/ml creatinine phosphokinase, 22 mM phosphocreatine, and 4 mM Mg2+-ATP (300 mosmol). Drugs were applied with a fast-exchange flow-tube perfusion
system driven by motor (Warner Instrument Co.). Agonists were applied
at 30-60-s intervals. The neurosteroids, PS (5-pregnen-3 -ol-20-one sulfate), pregnenolone hemisuccinate (PHS; 5-pregnen-3 -ol-20-one hemisuccinate), 5 -pregnan-3 -ol-20-one sulfate(3 5 PS), and
5 -pregnan-3 -ol-20-one hemisuccinate (3 5 PHS), were obtained
from Steraloids Inc. (Newport, RI). Steroid solutions were prepared as
100-250 mM stocks in Me2SO. The final
Me2SO concentration of all recording solutions was between 0.01% and 0.05%. Identical concentrations of Me2SO were
added to control solutions. All experiments were performed at room
temperature (23-25 °C).
Data were acquired and analyzed with either the Neuropro software (RC
Electronics, Santa Barbara, CA) or pClamp7 (Axon Instruments). Modulation of NMDA, kainate, and GABAA responses by
neurosteroids is presented as percent change,
[(I'/I) 1] × 100%, where I
is the average of control responses obtained before application and after washout of steroid, and I' is the average of
agonist-induced responses obtained from the same cell in the presence
of steroid.
Single-channel Measurements--
Single-channel recordings were
obtained in the cell-attached configuration to avoid alterations in
intracellular modulators of NMDA-R function. The patch solution
contained 10 µM NMDA and 1 µM glycine in a
solution containing 70 mM NaCl, 70 mM
Na2SO4, 10 mM HEPES, 1.2 mM CaCl2, 5 mM
Cs2SO4, 33 mM glucose, pH 7.4, and
300 mosmol. The pipette potential was +20 mV. Events were recorded with
an Axopatch 200B amplifier (Axon Instruments) and stored on digital
tape using a digital audio tape recorder (Panasonic SV3800).
Pipettes were pulled from borosilicate glass, lightly fire-polished,
and coated with Sylgard (Dow Corning, MI). Recordings were played back
and acquired and analyzed using the pClamp7 program (Axon Instruments).
Single-channel currents were initially filtered at 2 kHz and sampled at
5 kHz. Only patches with stable basal activities were used. The single
channel open probability was determined from the ratio of the time
spent in the open state to the duration of recording:
Po = (t1 + t2 + ... + tn)/Nttot, where t
is the amount of time that n channels are open, and
N is the maximum number of levels observed in the recording.
Open times were obtained with the pStat 6.0 computer program (Axon
Instruments) by fitting plots of event number versus open
time to exponential functions using the Marquardt algorithm. Closed
times were obtained in the same manner from plots of event number
versus log of closed time.
Western Immunoblots
Hippocampi from two P3 neonates, each from 3-6 different
litters per diet group, were homogenized by sonication and analyzed by
SDS-polyacrylamide gel electrophoresis and Western immunoblot assays.
Anti-NR2A, -2B, -2C, NR1-N1, NR1-C1, and NR1-C2 antibodies were
produced, purified, and characterized in the laboratory of Dr. Browning
at the University of Colorado Health Sciences Center. Anti-NR1
antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA).
Detection of bound antibodies was performed by chemiluminescence using
a kit from Roche Molecular Biochemicals. Densitometric analysis of
Western blot chemiluminescence x-ray films were performed using an
Image-Pro® Plus image analysis system (Media
Cybernetics, Silver Spring, MD). In all cases, a protein
standard curve was generated from a single homogenate of adult rat
hippocampal tissue kept at 80 °C. This standard curve was included
in the same membrane (using 15-well combs) as samples from control and
ethanol-treated animals. This curve was used to calculate relative
units of protein concentrations. We selected the appropriate bands and
measured relative optical density with respect to these standards. To
correct for variations in protein loading, concentrations of all
samples were normalized against -tubulin levels (anti- -tubulin
monoclonal antibody was from Sigma). Relative protein concentrations
are expressed as relative units (R.U.) of protein/R.U. of tubulin.
Statistical Analysis
The potentiating or inhibiting effects of neurosteroids were
quantified with respect to the average of control and washout responses. Neurosteroid dose response curves were fitted to
four-parameter logistic equations (sigmoid) using GraphPad Prizm
computer program (San Diego, CA). Statistical comparison of the effect
of neurosteroids among the three diet groups was performed by ANOVA
followed by Bonferroni's post hoc test. Effect of multiple
concentrations of PS on neurons from all three diet groups were
analyzed by two-way ANOVA. Effects of PS on non-NMDA and
GABAA receptor function in cells from the pair-fed
versus fetal ethanol-exposed groups were analyzed by
t test. In all cases, a p < 0.05 was
considered to indicate statistical significance.
 |
RESULTS |
Fetal Ethanol Exposure Paradigm--
Table
I summarizes the results of the feeding
paradigm used in this study (values are mean ± S.E. of 34-43
dams/diet group). No statistical differences were found in diet
consumption, total number of newborns, live newborns, or the average
mean weight of live newborns among the three diet groups. Furthermore,
no gross anatomical abnormalities were noted at birth in the fetal ethanol-exposed animals.
View this table:
[in this window]
[in a new window]
|
Table I
Comparison of liquid diet consumption and the effects of diets on
offspring at birth
Values are mean ± S.E. of 36, 43, and 40 dams for the ad
libitum, pair-fed, and fetal ethanol groups, respectively.
|
|
Effects of Prenatal Ethanol Exposure on Basic NMDA-R
Function--
Shown in Fig. 1 are NMDA
dose response curves recorded in the whole-cell patch clamp
configuration for neurons from the ad libitum control,
pair-fed control, and fetal ethanol-exposed groups. Fig. 1A
shows examples of currents obtained by increasing concentrations of
NMDA in the presence of a constant glycine (1 µM)
concentration. Fig. 1B shows a summary graph of NMDA dose
response curves obtained from neurons from the three feeding groups
(n = 6-9 neurons from 2-3 different litters per diet
group). Data were normalized with respect to maximum NMDA (100 µM) currents. The EC50 concentrations were
11 ± 1, 12 ± 1, and 13 ± 1 µM for
neurons from the ad libitum control, pair-fed control, and
the fetal ethanol-exposed groups, respectively. The Hill slope was
~1.4 for all treatment groups. It should be noted that we did not
find a difference in NMDA-R maximum current densities
(pA/picofarads) (Fig. 1B, inset). Current densities were 11 ± 1, 11 ± 1, and 13 ± 1 pA/picofarads for neurons from the ad libitum
control, pair-fed control, and the fetal ethanol-exposed groups,
respectively (n = 21-23 neurons from 3-4 different
litters per diet group).

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 1.
NMDA dose response curves recorded in the
whole-cell patch clamp configuration from cultured hippocampal
neurons. A, sample currents from ad libitum
control and fetal ethanol-exposed groups obtained by increasing
concentrations of NMDA in presence of a constant glycine (1 µM) concentration (scale bar represents 100 pA
and 200 ms). B, summary graph of NMDA dose response curves
obtained from all three feeding groups (n = 6-9
neurons from 2-3 different litters per group). Data were normalized
with respect to maximum NMDA (100 µM) currents. The
inset in panel B shows the NMDA receptor maximum
current densities (pA/picofarads) for neurons from the ad
libitum control, pair-fed control, and the fetal ethanol-exposed
groups, respectively (n = 21-23 neurons from 3-4
different litters per group). C, summary graph of
7-chlorokynurenate (7-CKA) competition curves obtained from
all three feeding groups (n = 4-5 neurons from 2-3
different litters per group) in the presence of a constant
concentration of NMDA (100 µM) and glycine (1 µM).
|
|
We also measured dose response curves for 7-chlorokynurenate, a
competitive antagonist of the glycine co-agonist site of NMDA-Rs (Fig.
1C), in the presence of constant NMDA (100 µM)
plus glycine (1 µM) concentrations (n = 4-5 neurons from 2-3 litters per diet group). The IC50
concentrations were 83 ± 18, 57 ± 17, and 93 ± 29 nM for neurons from the ad libitum control,
pair-fed control, and the fetal ethanol-exposed groups, respectively.
Statistical analysis did not reveal significant differences among these
diet groups.
We also assessed the effect of fetal ethanol exposure on NMDA-R
function at the single channel level. Fig.
2 shows sample tracings obtained from
neurons from pair-fed and fetal ethanol-exposed groups in the
cell-attached configuration. The patch solution contained 10 µM NMDA and 1 µM glycine. Single channel
parameters are summarized in Table II. We
did not detect any statistically significant differences in any of
these parameters among the three diet groups. Since resting membrane
potentials cannot be determined in the cell-attached mode,
single-channel conductance was not calculated.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 2.
Sample tracings from cell-attached
single-channel recordings obtained from neurons from pair-fed and fetal
ethanol-exposed neonatal rats. The patch solution contained 10 µM NMDA and 1 µM glycine. The pipette
potential was +20 mV. Single channel parameters are summarized in Table
II. Scale represents 10 pA and 40 ms.
|
|
Positive Modulation of NMDA-R by Neurosteroids--
Sample
tracings illustrating the effects of 50 µM PS on currents
induced by application of 50 µM NMDA on cultured
hippocampal neurons from ad libitum, pair-fed, and fetal
ethanol-exposed neonatal rats are shown in Fig.
3A. PS produced a significant
potentiation of NMDA-R-mediated currents in cells from the ad
libitum and the pair-fed groups but not in cells from the fetal
ethanol-exposed group (Table III). The
reduction in the effects of PS was evident at different concentrations
of this neurosteroid (Fig. 3B).

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 3.
Fetal alcohol exposure affects modulation of
NMDA-R by PS. A, sample tracings showing the effect of
50 µM PS on currents gated by 50 µM NMDA in
cultured hippocampal neurons from ad libitum control,
pair-fed control, and fetal ethanol-exposed neonatal rats (scale
bar is 100 pA and 200 ms). B, prenatal ethanol exposure
significantly (p < 0.02 by two-way ANOVA) reduces the
action of different concentrations of PS on currents gated by 50 µM NMDA in neurons from the fetal ethanol-exposed group
(for each point, n = 4-7 neurons from 2-8 different
litters per group).
|
|
View this table:
[in this window]
[in a new window]
|
Table III
Effect of fetal ethanol exposure on modulation of ligand-gated ion
channel currents by PS (50 µM)
Values are mean ± S.E. Numbers of neurons tested are given in
parentheses. Neurons were obtained from 5-8 different litters per diet
group for NMDA experiments and from one litter per diet group for the
non-NMDA and GABAA experiments.
|
|
Shown in Fig. 4A are sample
traces illustrating the effect of PHS on NMDA-R-mediated currents in
all the three diet groups. In neurons from ad libitum
controls, pair-fed controls, and fetal ethanol-exposed rats, the
amplitude of these currents in the presence of 50 µM PHS
corresponded to 53 ± 9% (n = 6 neurons from 3 different litters), 55 ± 13% (n = 6 neurons from
3 different litters), and 17 ± 8% (n = 8 neurons
from 2 different litters) of control, respectively (Fig.
4B).

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 4.
Fetal alcohol exposure affects
modulation of NMDA-R by PHS. A, sample tracings showing the
effect of 50 µM PHS on currents gated by 50 µM NMDA in cultured hippocampal neurons from ad
libitum control, pair-fed control, and fetal ethanol-exposed
neonatal rats (scale bar is 100 pA and 200 ms).
B, summary of the effect of 50 µM PHS in the
three diet groups (for each point, n = 6-8 neurons
from 2-3 different litters per group; *, p < 0.02 by
one-way ANOVA followed by Bonferroni's post hoc
test).
|
|
Statistical analysis indicated that the effect of both PS and PHS was
significantly different in neurons from ethanol-exposed rats
versus ad libitum and pair-fed controls
(p < 0.02 by ANOVA followed by Bonferroni's test).
The results of these experiments suggest that modulation of NMDA-Rs by
neurosteroids that potentiate receptor function is impaired by prenatal
ethanol exposure.
Modulation of NMDA-R by Negative Modulating
Neurosteroids--
Shown in Fig.
5A are sample tracings
illustrating the effect of 3 5 PS, a negative neurosteroid
modulator of NMDA-Rs. In neurons from ad libitum control,
pair-fed controls and fetal ethanol-exposed rats, the amplitude of
these currents in the presence of 100 µM 3 5 PS was
decreased by 52 ± 12% (n = 9 neurons from 1 litter), 44 ± 15% (n = 7 neurons from 2 different litters), and 40 ± 4% (n = 6 neurons
from 2 different litters) in comparison to control, respectively (Fig.
5B). The amplitude of NMDA-R currents in neurons from the
same diet groups in the presence of 100 µM 3 5 PHS
were decreased to 60 ± 23% (n = 9 neurons from 2 different litters), 78 ± 17% (n = 7 neurons from
3 different litters), and 73 ± 23% (n = 7 neurons from 3 different litters) of control values (Fig. 5C). Statistical analysis indicated that the effect of both
3 5 PS and 3 5 PHS was not significantly different in neurons
from ethanol-exposed rats versus ad libitum and
pair-fed controls (p > 0.05 by ANOVA followed by
Bonferroni's test).

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 5.
Actions of negative modulating neurosteroids
3 5 PS and
3 5 PHS are unaffected
by fetal ethanol exposure. A, sample tracings showing
the effect of 100 µM 3 5 PS on currents gated by 50 µM NMDA in cultured hippocampal neurons from ad
libitum control, pair-fed control, and fetal ethanol-exposed rats
(scale bar is 100 pA and 200 ms). B, summary of
the effect of 100 µM 3 5 PS (n = 6-7
neurons from 1-2 different litters per group). C, summary
of the effect of 100 µM 3 5 PHS (n = 7-9 neurons from 2-3 different litters per group).
|
|
Modulation of Non-NMDA and GABAA Receptors by
Neurosteroids--
PS has been shown to selectively modulate other
classes of ionotropic receptors. PS inhibits AMPA/kainate and
GABAA receptors (27, 36, 37). Thus, we performed
experiments to investigate possible alterations in the neurosteroid
modulation on the function of these receptors in neurons from animals
prenatally exposed to ethanol. In neurons from the pair-fed control and
fetal ethanol-exposed rats, application of 50 µM PS
inhibited to the same extent currents elicited by 100 µM
kainate (Table III). 50 µM PS also inhibited by the same
magnitude currents gated by 50 µM GABA (Table III) in
neurons from the pair-fed control and fetal ethanol-exposed neonatal
rats. Statistical analysis (t test) indicated that the effect of PS was not significantly different in neurons from
ethanol-exposed rats versus pair-fed controls (Table
III).
Expression Levels of NMDA Receptor Subunits--
Fig.
6 shows examples of Western immunoblot
analyses of NMDA receptor subunit expression in hippocampal homogenates
from P3 neonates from the ad libitum, pair-fed and fetal
ethanol groups. These examples illustrate that the levels of these
subunits are not affected by fetal ethanol exposure. NR2A subunit
levels were 0.46 ± 0.13, 0.39 ± 0.09, and 0.28 ± 0.13 R.U. of protein/R.U. of tubulin, respectively (n = 3 homogenates, each from a different litter). NR2B subunit levels were
0.34 ± 0.06, 0.37 ± 0.10, and 0.38 ± 0.05 R.U. of
protein/R.U. of tubulin, respectively (n = 6 homogenates, each from a different litter). NR2C subunit levels were
0.27 ± 0.02, 0.29 ± 0.03, and 0.29 ± 0.03 R.U. of
protein/R.U. of tubulin, respectively (n = 6 homogenates, each from a different litter). NR1 subunit levels were
0.76 ± 0.12, 1.1 ± 0.22, and 0.92 ± 0.14 R.U. of
protein/R.U. of tubulin, respectively (n = 6 homogenates, each from a different litter). Levels of NR1 subunits containing the N1 cassette (NR1-N1) were 1.04 ± 0.15, 1.03 ± 0.18, and 0.86 ± 0.13 R.U. of protein/R.U. of tubulin,
respectively (n = 5 homogenates, each from a different
litter). Levels of NR1 subunits containing the C2 cassette (NR1-C2)
were 0.61 ± 0.08, 0.71 ± 0.11, and 0.65 ± 0.03 R.U.
of protein/R.U. of tubulin (n = 5 homogenates, each
from a different litter). Expression of NR1 subunits containing the C1
cassette (NR1-C1) was not detected (n = 6 homogenates,
each from a different litter).

View larger version (61K):
[in this window]
[in a new window]
|
Fig. 6.
Expression of NMDA-R subunits in hippocampal
homogenates from neonates belonging to the ad libitum,
pair-fed, and fetal ethanol-exposed groups. Shown are examples of
Western immunoblots for the indicated NMDA-R subunits, including NR1
subunits containing the N1, C1, and C2 cassettes. Also shown are
samples of immunoblots for -tubulin, which were used to correct for
variations in protein loading. Each of the bands shown per group is
from a homogenate prepared from the hippocampi of two neonates (P3-4).
Each homogenate was obtained from animals belonging to different
litters. Shown on the left are protein standard curves generated from a
single homogenate of adult rat hippocampal tissue of known protein
concentration. The protein amounts loaded per standard curve
lane were 5, 10, 15, and 20 µg. This curve was used to
calculate relative units of protein concentrations. Note the expression
of NR1-C1 subunits in the adult homogenates but not in the neonatal
homogenates. See text for details on the methodology and the results of
densitometric analyses.
|
|
 |
DISCUSSION |
Contrary to expectations, we found that the basic parameters of
NMDA-R function were unaffected by our fetal ethanol exposure paradigm.
We expected to detect alterations in NMDA-R function because a number
of studies have consistently found reductions in NMDA-R-mediated
responses in neurons from the offspring of ethanol-exposed dams. One of
these studies showed that exposure of pregnant rats to blood alcohol
levels of ~0.04% resulted in a long term reduction of
NMDA-dependent responses in CA1 hippocampal pyramidal
neurons in slices from the adult offspring of these rats (38). Studies
using dispersed neurons have also demonstrated prenatal ethanol
exposure-induced reductions in NMDA-R function. Fetal ethanol exposure
to blood alcohol levels ranging between 0.03 and 0.15% was shown to
reduce NMDA receptor-mediated increases in intracellular
Ca2+ levels in acutely dissociated neurons from either the
whole brain (12, 13) or specific central nervous system regions such as the hippocampus, forebrain, and cerebellum of newborn rats (14). In
contrast to these studies, we did not detect any changes in hippocampal
NMDA-R function at neither the whole-cell or single-channel levels
(Figs. 1 and 2). There are multiple factors that could account for the
differences between our results and those of the Ca2+-imaging studies discussed above. First, it must be
considered that, for some of those studies (13, 14), pregnant rats were exposed to higher blood alcohol levels (0.12-0.15%) than those that
are achieved with our diet (~0.08%) (34). Second, for the Ca2+-imaging studies, NMDA-R function was assessed in
neurons acutely dissociated from newborn rats within 24 h after
birth; i.e. during the immediate period of withdrawal from
in utero ethanol exposure (12-14). In contrast, we measured
NMDA receptor function in hippocampal neuronal cultures prepared 3-4
days after withdrawal from fetal ethanol exposure, and we performed
electrophysiological recordings after culturing these neurons for an
additional 6-7 days in ethanol-free media. Finally, it must be kept in
mind that Ca2+-imaging techniques do not directly assess
NMDA-R function but measure the change in intracellular
Ca2+ levels in response to NMDA-R activation.
NMDA-R-induced changes in intracellular Ca2+ levels have
been shown to be complex, involving, for example, the release of
Ca2+ from intracellular stores (39) and the activation of
voltage-gated Ca2+ channels (40). Thus, the findings of
these Ca2+-imaging studies must be interpreted cautiously
considering that prenatal ethanol exposure could have affected
NMDA-R-dependent Ca2+ elevations at a point
downstream of the NMDA-R itself. Despite these technical differences
between studies, it should be emphasized that an important conclusion
of our study is that prenatal ethanol exposure may not produce
long-lasting changes in hippocampal NMDA-R function in all cases.
A positive finding of our study was that prenatal ethanol exposure
affects the sensitivity of NMDA-R to neurosteroids (Figs. 3 and 4 and
Table III). In agreement with previous reports (26-28, 41), we found
that both PS and PHS produced significant potentiation of
NMDA-R-mediated whole-cell currents in cultured hippocampal neurons
from control rats. In contrast, the NMDA-R potentiating actions of
these neurosteroids were significantly reduced in neurons obtained from
neonates prenatally exposed to ethanol. Interestingly, the actions of
neurosteroids that inhibit NMDA-R function, such as 3 5 PS and
3 5 PHS, were not significantly affected by prenatal ethanol
exposure (Fig. 5). Based on competition studies, Park-Chung et
al. (26) determined that positive and negative neurosteroid modulators of NMDA-R function act at specific, extracellularly directed
sites that are distinct from one another. Thus, prenatal ethanol
exposure appears to selectively affect the site of action of positive
neurosteroid modulators of NMDA-Rs. The mechanism underlying this
selective effect of prenatal ethanol exposure is unclear at the present
time because the mechanism of the modulatory actions of neurosteroids
on NMDA-R has yet to be determined. It is noteworthy, however, that
studies with recombinant receptors suggest that subunit composition is
an important determinant of the sensitivity of the NMDA-R to
neurosteroids (28). However, we did not detect any changes in the
expression levels of NMDA-R subunits in hippocampal homogenates from
fetal ethanol-exposed neonates. Consequently, another mechanism must
underlie this decrease in sensitivity of NMDA-Rs to positive
neurosteroid modulators. A possible mechanism could involve alterations
in NMDA-R phosphorylation. Although the role of phosphorylation on
neurosteroid actions on NMDA-R has not been studied, changes in protein
phosphorylation do regulate the sensitivity to neurosteroids of
voltage-gated Ca2+ channels (42) and GABAA
receptors (43). Therefore, it is possible that the mechanism of action
of prenatal ethanol exposure involves a change in the phosphorylation
state of the NMDA-R, and we are currently examining this possibility experimentally.
It should be noted that prenatal ethanol exposure was recently shown to
alter modulation of another ligand-gated ion channel by neurosteroids.
Allan et al. (34) report that neurosteroid modulation of
GABAA receptors is altered in the adult offspring of dams
exposed to a diet of identical composition to the one used in our
study. Prenatal ethanol exposure induced a reduction in the modulatory
effects of alphaxalone and PS on GABA-stimulated 36Cl flux into membrane vesicles prepared
from the medial frontal cortex (34). In hippocampal membrane vesicles,
prenatal ethanol exposure did not change the effects of PS but enhanced
the positive modulatory effects of alphaxalone (34). The results of
these experiments with hippocampal microsacs are consistent with our finding that the inhibitory effect of PS on GABAA receptors
is unaltered in cultured hippocampal neurons from the fetal
ethanol-exposed group. Thus, prenatal ethanol exposure appears to
selectively target neurosteroid modulation of NMDA receptors in the
hippocampus. Our finding that fetal ethanol exposure did not alter
neurosteroid modulation of kainate-induced currents in hippocampal
neurons further supports this conclusion.
The findings of the present study are significant because they provide,
at least in part, a plausible mechanistic explanation for the
alterations in the behavioral responses to neurosteroids of prenatally
ethanol-exposed animals (44, 45). PS was shown to increase the number
of ultrasonic vocalizations in pups subjected to maternal
separation-induced stress (33), and this anxiogenic effect of PS was
found to be reduced in pups from ethanol-exposed dams (33). We
postulate that this decrease in the behavioral responses to exogenous
PS could be due, in part, to alterations in the sensitivity of NMDA
receptors to this neurosteroid in the hippocampus and other brain
regions involved in the stress response. It would be important to
determine if modulation of the stress response by endogenous
neurosteroids is also altered by fetal ethanol exposure.
In conclusion, we found that prenatal exposure to ~0.08% blood
alcohol levels does not produce detectable alterations in NMDA receptor
function in neonatal hippocampal neurons after 6-7 days in culture.
However, we found that exposure to ethanol in utero alters
the actions of neurosteroids that positively modulate NMDA-R function
and that this effect is not due to an alteration in the expression
levels of NMDA-R subunits. A challenging task for future research will
be to determine the mechanism and the precise contribution of these
alterations to the pathophysiology of learning disabilities associated
with fetal alcohol syndrome and alcohol-related neurodevelopmental disorders.
 |
ACKNOWLEDGEMENTS |
We thank Rafael Galindo, Linda Beyer-Smith,
and Alex De La Torre for assistance with rat breeding. We are also
grateful to Drs. Bill Shuttleworth, Michael Wilson, and Don Partridge
for advice and helpful discussions and to Rita A. Cardoso for technical assistance.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grants AA00227 (to C. F. V.) and AA06548 (to D. D. S.),
Fundação de Amparo à Pesquisa do Estado de São
Paulo, Brazil, Postdoctoral Fellowship 98/12714-6 (to E. T. C.), and
a Research Resources grant from the Howard Hughes Medical Institute to
the University of New Mexico School of Medicine.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Dept. of Neurosciences,
University of New Mexico Health Sciences Center, Basic Medical Sciences
Building, Rm. 145, Albuquerque, NM 87131-5223. Tel.: 505-272-3128; Fax:
505-272-8082; E-mail: fvalenzuela@salud.unm.edu.
Published, JBC Papers in Press, September 14, 2000, DOI 10.1074/jbc.M004136200
 |
ABBREVIATIONS |
The abbreviations used are:
NMDA, N-methyl-D-aspartate;
PS, pregnenolone sulfate,
5-pregnen-3 -ol-20-one sulfate;
PHS, pregnenolone hemisuccinate,
5-pregnen-3 -ol-20-one hemisuccinate;
3 5 PS, 5 -pregnan-3 -ol-20-one sulfate;
3 5 PHS, 5 -pregnan-3 -ol-20-one hemisuccinate;
ANOVA, analysis of variance;
GABA, -aminobutyric acid;
R.U., relative units.
 |
REFERENCES |
| 1.
|
Larkby, C.,
and Day, N.
(1997)
Alcohol Health Res. World
21,
192-198
|
| 2.
|
Streissguth, A. P.,
Bookstein, F. L.,
Sampson, P. D.,
and Barr, H. M.
(1989)
Neurotoxicol. Teratol.
11,
493-507
|
| 3.
|
Mattson, S. N.,
Riley, E. P.,
Delis, D. C.,
Stern, C.,
and Jones, K. L.
(1996)
Alcohol Clin. Exp. Res.
20,
810-816
|
| 4.
|
Uecker, A.,
and Nadel, L.
(1996)
Neuropsychologia
34,
209-223
|
| 5.
|
Uecker, A.,
and Nadel, L.
(1998)
Am. J. Ment. Retard.
103,
12-18
|
| 6.
|
Costa, E. T.,
Savage, D. D.,
and Valenzuela, C. F.
(2000)
Alcohol Clin. Exp. Res.
24,
706-715
|
| 7.
|
Savage, D. D.,
Montano, C. Y.,
Otero, M. A.,
and Paxton, L. L.
(1991)
Alcohol
8,
193-201
|
| 8.
|
Savage, D. D.,
Queen, S. A.,
Sanchez, C. F.,
Paxton, L. L.,
Mahoney, J. C.,
Goodlett, C. R.,
and West, J. R.
(1992)
Alcohol
9,
37-41
|
| 9.
|
Diaz-Granados, J. L.,
Spuhler-Phillips, K.,
Lilliquist, M. W.,
Amsel, A.,
and Leslie, S. W.
(1997)
Alcohol Clin. Exp. Res.
21,
874-881
|
| 10.
|
Abdollah, S.,
and Brien, J. F.
(1995)
Alcohol
12,
369-375 fgcg
|
| 11.
|
Hughes, P. D.,
Kim, Y. N.,
Randall, P. K.,
and Leslie, S. W.
(1998)
Alcohol Clin. Exp. Res.
22,
1255-1261
|
| 12.
|
Weaver, M. S.,
Lee, Y. H.,
Morris, J. L.,
Randall, P. K.,
Schallert, T.,
and Leslie, S. W.
(1993)
Alcohol Clin. Exp. Res.
17,
643-650
|
| 13.
|
Lee, Y. H.,
Spuhler-Phillips, K.,
Randall, P. K.,
and Leslie, S. W.
(1994)
J. Pharmacol Exp. Ther.
271,
1291-1298
|
| 14.
|
Spuhler-Phillips, K.,
Lee, Y. H.,
Hughes, P.,
Randoll, L.,
and Leslie, S. W.
(1997)
Alcohol Clin. Exp. Res.
21,
68-75
|
| 15.
|
Gruol, D. L.,
Ryabinin, A. E.,
Parsons, K. L.,
Cole, M.,
Wilson, M. C.,
and Qiu, Z.
(1998)
Brain Res.
793,
12-20
|
| 16.
|
Ebralidze, A. K.,
Rossi, D. J.,
Tonegawa, S.,
and Slater, N. T.
(1996)
J. Neurosci.
16,
5014-5025
|
| 17.
|
Forrest, D.,
Yuzaki, M.,
Soares, H. D.,
Ng, L.,
Luk, D. C.,
Sheng, M.,
Stewart, C. L.,
Morgan, J. I.,
Connor, J. A.,
and Curran, T.
(1994)
Neuron
13,
325-338
|
| 18.
|
Iwasato, T.,
Erzurumlu, R. S.,
Huerta, P. T.,
Chen, D. F.,
Sasaoka, T.,
Ulupinar, E.,
and Tonegawa, S.
(1997)
Neuron
19,
1201-1210
|
| 19.
|
Kadotani, H.,
Hirano, T.,
Masugi, M.,
Nakamura, K.,
Nakao, K.,
Katsuki, M.,
and Nakanishi, S.
(1996)
J. Neurosci.
16,
7859-7867
|
| 20.
|
Kishimoto, Y.,
Kawahara, S.,
Kirino, Y.,
Kadotani, H.,
Nakamura, Y.,
Ikeda, M.,
and Yoshioka, T.
(1997)
Neuroreport
8,
3717-3721
|
| 21.
|
McHugh, T. J.,
Blum, K. I.,
Tsien, J. Z.,
Tonegawa, S.,
and Wilson, M. A.
(1996)
Cell
87,
1339-1349
|
| 22.
|
Sprengel, R.,
Suchanek, B.,
Amico, C.,
Brusa, R.,
Burnashev, N.,
Rozov, A.,
Hvalby, O.,
Jensen, V.,
Paulsen, O.,
Andersen, P.,
Kim, J. J.,
Thompson, R. F.,
Sun, W.,
Webster, L. C.,
Grant, S. G.,
Eilers, J.,
Konnerth, A.,
Li, J.,
McNamara, J. O.,
and Seeburg, P. H.
(1998)
Cell
92,
279-289
|
| 23.
|
Okabe, S.,
Collin, C.,
Auerbach, J. M.,
Meiri, N.,
Bengzon, J.,
Kennedy, M. B.,
Segal, M.,
and McKay, R. D.
(1998)
J. Neurosci.
18,
4177-4188
|
| 24.
|
Bergeron, R.,
de Montigny, C.,
and Debonnel, G.
(1996)
J. Neurosci.
16,
1193-1202
|
| 25.
|
Compagnone, N. A.,
and Mellon, S. H.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
4678-4683
|
| 26.
|
Park-Chung, M.,
Wu, F. S.,
Purdy, R. H.,
Malayev, A. A.,
Gibbs, T. T.,
and Farb, D. H.
(1997)
Mol. Pharmacol.
52,
1113-1123
|
| 27.
|
Wu, F. S.,
Gibbs, T. T.,
and Farb, D. H.
(1991)
Mol. Pharmacol.
40,
333-336
|
| 28.
|
Yaghoubi, N.,
Malayev, A.,
Russek, S. J.,
Gibbs, T. T.,
and Farb, D. H.
(1998)
Brain Res.
803,
153-160
|
| 29.
|
Flood, J. F.,
Morley, J. E.,
and Roberts, E.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
10806-10810
|
| 30.
|
Mathis, C.,
Paul, S. M.,
and Crawley, J. N.
(1994)
Psychopharmacol. Ser. (Berl)
116,
201-206
|
| 31.
|
Mathis, C.,
Vogel, E.,
Cagniard, B.,
Criscuolo, F.,
and Ungerer, A.
(1996)
Neuropharmacology
35,
1057-1064
|
| 32.
|
Vallee, M.,
Mayo, W.,
Darnaudery, M.,
Corpechot, C.,
Young, J.,
Koehl, M.,
Le Moal, M.,
Baulieu, E. E.,
Robel, P.,
and Simon, H.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
14865-14870
|
| 33.
|
Zimmerberg, B.,
and McDonald, B. C.
(1996)
Pharmacol. Biochem. Behav.
55,
541-547
|
| 34.
|
Allan, A. M.,
Wu, H.,
Paxton, L. L.,
and Savage, D. D.
(1998)
J. Pharmacol Exp. Ther.
284,
250-257
|
| 35.
|
Lieber, C. S.,
and DeCarli, L. M.
(1982)
Alcohol Clin. Exp. Res.
6,
523-531
|
| 36.
|
Majewska, M. D.,
and Schwartz, R. D.
(1987)
Brain Res.
404,
355-360
|
| 37.
|
Rabow, L. E.,
Russek, S. J.,
and Farb, D. H.
(1995)
Synapse
21,
189-274
|
| 38.
|
Morrisett, R. A.,
Martin, D.,
Wilson, W. A.,
Savage, D. D.,
and Swartzwelder, H. S.
(1989)
Alcohol
6,
415-420
|
| 39.
|
Emptage, N.,
Bliss, T. V.,
and Fine, A.
(1999)
Neuron
22,
115-124
|
| 40.
|
Calton, J. L.,
Kang, M. H.,
Wilson, W. A.,
and Moore, S. D.
(2000)
J. Neurophysiol.
83,
685-692
|
| 41.
|
Irwin, R. P.,
Maragakis, N. J.,
Rogawski, M. A.,
Purdy, R. H.,
Farb, D. H.,
and Paul, S. M.
(1992)
Neurosci. Lett.
141,
30-34
|
| 42.
|
ffrench-Mullen, J. M.,
Danks, P.,
and Spence, K. T.
(1994)
J. Neurosci.
14,
1963-1977
|
| 43.
|
Fancsik, A.,
Linn, D. M.,
and Tasker, J. G.
(2000)
J. Neurosci.
20,
3067-3075
|
| 44.
|
Zimmerberg, B.,
Brunelli, S. A.,
and Hofer, M. A.
(1994)
Pharmacol. Biochem. Behav.
47,
735-738
|
| 45.
|
Zimmerberg, B.,
Drucker, P. C.,
and Weider, J. M.
(1995)
Pharmacol. Biochem. Behav.
51,
463-468
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Dubois, M. Naassila, M. Daoust, and O. Pierrefiche
Early chronic ethanol exposure in rats disturbs respiratory network activity and increases sensitivity to ethanol
J. Physiol.,
October 1, 2006;
576(1):
297 - 307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mameli, M. Carta, L. D. Partridge, and C. F. Valenzuela
Neurosteroid-Induced Plasticity of Immature Synapses via Retrograde Modulation of Presynaptic NMDA Receptors
J. Neurosci.,
March 2, 2005;
25(9):
2285 - 2294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Meyer, M. Carta, L. D. Partridge, D. F. Covey, and C. F. Valenzuela
Neurosteroids Enhance Spontaneous Glutamate Release in Hippocampal Neurons. POSSIBLE ROLE OF METABOTROPIC sigma 1-LIKE RECEPTORS
J. Biol. Chem.,
August 2, 2002;
277(32):
28725 - 28732.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. C. Bailey, J. F. Brien, and J. N. Reynolds
Chronic Prenatal Ethanol Exposure Increases GABAA Receptor Subunit Protein Expression in the Adult Guinea Pig Cerebral Cortex
J. Neurosci.,
June 15, 2001;
21(12):
4381 - 4389.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|